척추 압박 골절(VCF) 치료 기기 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, vertebral compression fracture devices market size in 2026 is estimated at USD 1.44 billion, growing from 2025 value of USD 1.33 billion with 2031 projections showing USD 2.11 billion, growing at 7.99% CAGR over 2026-2031.

This report is Segmented by Product Type (Balloon Kyphoplasty Devices, Vertebroplasty Devices, and More), Material (PMMA Bone Cement, Bio-active/Bioresorbable Cement, and More), Surgery (Open Spine Surgery and More), End User (Hospitals, Ambulatory Surgical Centers, and More), and Geography (North America and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Vertebral Compression Fracture Devices Market Trends and Insights

Rising prevalence of osteoporosis-linked VCFs

Global osteoporosis is forecast to affect 263.2 million people by 2034, exposing a much larger cohort to vertebral compression fractures. National studies echo the trend-12.2% fracture prevalence in urban Vietnam and heightened risk among Korean postmenopausal women. Even as age-standardized rates ease, absolute fracture counts climb because populations are aging, a pattern confirmed by international burden analyses. Screening gaps exacerbate the issue: only 25.7% of elderly Japanese spinal patients receive pre-operative bone mineral density tests, indicating untapped need for devices that stabilize fragile vertebrae.These factors ensure sustained demand for the vertebral compression fracture devices market.

Growing adoption of minimally invasive spinal procedures

Medicare data show ASC procedures cost less than hospital outpatient departments while delivering equivalent safety, a clear incentive for providers. Vertebral augmentation reduces median stays to 2.4 days compared with 10.8 days for conservative management, trimming direct costs to USD 4,737 versus USD 7,250. Same-day discharge protocols, stress-tested during COVID-19, achieved 100% success across 164 minimally invasive cases Precision keeps improving: a novel 2D navigation system reached 0.54 mm accuracy in spine models. Together these data points underline why clinicians increasingly prefer minimally invasive options, accelerating the vertebral compression fracture devices market.

Post-surgical complications (cement leakage, embolism)

Meta-analysis shows leakage in 46.2% of kyphoplasty cases, despite being the safest among augmentation options. Rare but severe sequelae include right-atrial perforation with pericardial tamponade and pulmonary cement embolism presenting as acute dyspnea. PMMA polymerization temperatures exceeding 70 °C can induce thermal necrosis at the bone interface. Modified cements and aspiration techniques drop leakage to 13% but require training and capital. These risks may curb near-term growth in the vertebral compression fracture devices market.

Other drivers and restraints analyzed in the detailed report include:

1. Increasing healthcare expenditure in emerging markets
2. Robust clinical evidence validating balloon kyphoplasty
3. Stringent regulatory & reimbursement hurdles

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Balloon kyphoplasty secured 44.02% of vertebral compression fracture devices market share in 2025 due to payer familiarity, straightforward workflows, and ample clinical proof. Expandable intravertebral implants, however, are growing at an 11.19% CAGR and challenge the incumbent modality by restoring vertebral height more effectively, as demonstrated in randomized trials of the SpineJack system. Conventional vertebroplasty retains market presence because of its lower cost and quick learning curve in resource-limited settings. Niche segments such as radio-frequency augmentation and vesselplasty solve complex anatomic challenges, expanding surgeon toolkits within the vertebral compression fracture devices market.

Engineering advances in expandable implants distribute endplate loads evenly, improving long-term biomechanics. The SPICO study confirmed shorter hospital stays and faster work resumption despite higher upfront device costs. Ancillary bone-cement delivery systems are also proliferating as surgeons prioritize precision; the Tripod-Fix device's retractable arms nearly eliminated leakage in early clinical use. New entrants must now pair hardware with integrated navigation software to gain traction in the vertebral compression fracture devices market.

PMMA continues to dominate with 55.98% share of vertebral compression fracture devices market size due to cost advantages and decades-long surgical familiarity. Yet bio-active and bioresorbable cements are accelerating at 12.49% CAGR because clinicians aim for osteointegration and reduced long-term foreign-body presence. Calcium-phosphate fillers and ceramic hybrids provide intermediate mechanical performance and resorb naturally, while enhanced PMMA variants integrate nano-tantalum carbide for higher radiopacity and osteogenic potential.

Three-year follow-up on calcium-phosphate cement shows volume reduction without loss of stability. Hydroxyapatite/collagen composites deliver fusion rates comparable to iliac crest grafts but with less surgical trauma, hinting at broader spinal application. Material R&D will be a decisive lever for differentiation across the vertebral compression fracture devices industry, especially as payers scrutinize long-term outcomes.

Complete Report Scope:

• By Product Type
  • Balloon Kyphoplasty Devices
  • Vertebroplasty Devices
  • Expandable Intravertebral Implants
  • Radio-frequency Augmentation Systems
  • Vesselplasty & Mesh-containment Systems
  • Bone-cement Delivery Systems & Accessories
• By Material
  • PMMA Bone Cement
  • Bio-active / Bioresorbable Cement
  • Calcium-phosphate & Ceramic Fillers
  • Others
• By Surgery
  • Open Spine Surgery
  • Minimally-Invasive (Percutaneous) Surgery
• By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Trauma Centers
  • Specialty Spine Clinics
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America led with 38.90% share in 2025, leveraging mature reimbursement systems and sophisticated spine-care infrastructure. Medicare compares vertebral augmentation at USD 4,737 against USD 7,250 for conservative therapy, validating cost-effectiveness. ASC reimbursement reform shortened approval timelines, encouraging providers to transfer cases out of hospital outpatient departments. Canada's universal model and Mexico's episodic payment pilots also expand demand, each supported by regional training and NIH-sponsored clinical trials that power innovation in the vertebral compression fracture devices market.

Asia-Pacific is the fastest-growing theater at 10.31% CAGR through 2031, propelled by demographic shifts and healthcare modernization. Japan's osteoporosis screening deficit-only 25.7% of elderly fusion patients receive pre-operative scans-underscores latent demand. China speeds device approvals through its National Medical Products Administration fast-track, while India's elder cohorts benefit from proven post-surgical functional gains. Australia and South Korea pioneer early adoption of AI navigation, and Southeast Asian nations introduce bundled payments for minimally invasive spine surgery, collectively widening the vertebral compression fracture devices market footprint.

Europe advances steadily on the back of evidence-based medicine and pan-EU regulatory harmonization. Economic modeling projects EUR 2.8 billion in potential savings by 2040 if osteoporosis diagnosis rates improve. Germany, the United Kingdom, and France spearhead multicenter trials, while Southern Europe accelerates adoption through public-private partnership initiatives. Russia modernizes rural spine centers, tapping into EU research networks to upgrade procedural standards. South America and the Middle East & Africa lag but display growing interest in cost-optimized percutaneous approaches, indicating long-term contribution to the vertebral compression fracture devices market.

1. Medtronic
2. Stryker
3. Johnson & Johnson
4. Globus Medical
5. Merit Medical Systems
6. Orthofix Interventional
7. ZimVie
8. Spirit Spine Holdings
9. Spine Wave
10. Zavation
11. Joimax
12. IZI Medical Products
13. CareFusion / BD
14. Osseon LLC
15. VEXIM SA
16. Alphatec Holdings
17. SpineArt SA
18. Seawon Meditech
19. Icotec AG

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Prevalence Of Osteoporosis-Linked Vcfs
  • 4.2.2 Growing Adoption Of Minimally-Invasive Spinal Procedures
  • 4.2.3 Increasing Healthcare Expenditure In Emerging Markets
  • 4.2.4 Robust Clinical Evidence Validating Balloon Kyphoplasty
  • 4.2.5 Reimbursement Shift Toward ASC-Performed Augmentation
  • 4.2.6 AI-Enabled Navigation Lowering Cement-Leakage Risk
• 4.3 Market Restraints
  • 4.3.1 Post-Surgical Complications (Cement Leakage, Embolism)
  • 4.3.2 Stringent Regulatory & Reimbursement Hurdles
  • 4.3.3 Price Erosion Of Commoditized PMMA Bone Cement
  • 4.3.4 Limited Long-Term Evidence For Bio-Active Cements
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technology Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Bargaining Power of Suppliers
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Threat of New Entrants
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size and Growth Forecasts (Value-USD)

• 5.1 By Product Type
  • 5.1.1 Balloon Kyphoplasty Devices
  • 5.1.2 Vertebroplasty Devices
  • 5.1.3 Expandable Intravertebral Implants
  • 5.1.4 Radio-frequency Augmentation Systems
  • 5.1.5 Vesselplasty & Mesh-containment Systems
  • 5.1.6 Bone-cement Delivery Systems & Accessories
• 5.2 By Material
  • 5.2.1 PMMA Bone Cement
  • 5.2.2 Bio-active / Bioresorbable Cement
  • 5.2.3 Calcium-phosphate & Ceramic Fillers
  • 5.2.4 Others
• 5.3 By Surgery
  • 5.3.1 Open Spine Surgery
  • 5.3.2 Minimally-Invasive (Percutaneous) Surgery
• 5.4 By End User
  • 5.4.1 Hospitals
  • 5.4.2 Ambulatory Surgical Centers
  • 5.4.3 Trauma Centers
  • 5.4.4 Specialty Spine Clinics
  • 5.4.5 Others
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
  • 6.3.1 Medtronic
  • 6.3.2 Stryker Corporation
  • 6.3.3 Johnson & Johnson (DePuy Synthes)
  • 6.3.4 Globus Medical
  • 6.3.5 Merit Medical Systems
  • 6.3.6 Orthofix Interventional
  • 6.3.7 ZimVie
  • 6.3.8 Spirit Spine Holdings
  • 6.3.9 Spine Wave
  • 6.3.10 Zavation
  • 6.3.11 joimax GmbH
  • 6.3.12 IZI Medical Products
  • 6.3.13 CareFusion / BD
  • 6.3.14 Osseon LLC
  • 6.3.15 VEXIM SA
  • 6.3.16 Alphatec Holdings
  • 6.3.17 SpineArt SA
  • 6.3.18 Seawon Meditech
  • 6.3.19 Icotec AG

7 Market Opportunities and Future Outlook

• 7.1 White-Space and Unmet-Need Assessment